ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Oncology Trials: Accuracy And Alleviating The Patient Screening Burden

  Flatiron Health has unveiled an innovative service designed to enhance patient screening for clinical trials by integrating structured EHR data with machine learning and human analysis.

• The Impact Of RWD And Cloud Tech On Research, Health Outcomes

  Far too often, valuable data sources are siloed, disparate, and unusable. Learn how expansive datasets can empower the industry to advance clinical trials and outcomes research, benefiting all communities.

• Create Personalized Treatments With VR And RWD

  Dive into the ways this cutting-edge technology is revolutionizing how healthcare providers create personalized treatment plans for patients suffering from chronic low back pain (CLBP).

• Hidden Costs Of Data Cleaning: Build Quality At The Source

  Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

• A New Take On The Evolving Role Of AI In Clinical Trials

  Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.

• A Strategic Framework For Positive Site-Sponsor Relationships

  Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge.

• Fear Isn't A Strategy: Rethinking AI In Clinical Trials

  As AI restrictions rise, needed oversight is slowing trials. This piece explores how delays hurt patients and how sites and sponsors can modernize without sacrificing regulatory trust.

• Why Portable 6-Lead Devices Are The Future Of Cardiac Monitoring

  Explore advanced technologies that offer a remote solution to maintain rigorous standards for ECG assessment while adapting your trial to have a more patient-centered design.

• Data Distortions: When Statistics Can Lead Us Astray In Drug Safety

  Post-marketing signals and AE frequency comparisons need careful interpretation. Discover how confounding factors and misunderstood statistics often mislead drug safety professionals.

• How Modern Platforms Enable Connected Clinical Data Systems And Flexible Study Workflows

  Digital trials demand seamless data flow. APIs reduce manual work, improve oversight, and power flexible, connected study environments.